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ABSTRACT Osteoporosis is a global public health that affects postmenopausal women due to
the deﬁciency of estrogen, a hormone that plays an important role in the microarchitecture of bone
tissue. Osteoporosis predisposes to pathological bone fracture that can be repaired by conventional
methods. However, depending on the severity and quantity of bone loss, the use of autogenous
grafts or biomaterials such as hydroxyapatite might be necessary. The latter has received increas-
ing attention in the medical ﬁeld because of its good biological properties such as osteoconductivity
and biocompatibility with bone tissue. The objective of this study was to evaluate using histologic
and radiographic analyses, the osteogenic capacity of hydroxyapatite implanted into the femur of
rats with ovariectomy-induced osteoporosis. Eighteen rats were divided into three groups with six
animals in each: group nonovariectomized, bilaterally ovariectomized not receiving estrogen
replacement therapy, and bilaterally ovariectomized submitted to estrogen replacement therapy.
Defects were created experimentally in the distal epiphysis of the femur with a surgical drill and
ﬁlled with porous hydroxyapatite granules. The animals were sacriﬁced 8 weeks after surgery. The
volume of newly formed bone in the implant area was quantiﬁed by morphometrical methods. The
results were analyzed by ANOVA followed by the Tukey test (P < 0.05). The hydroxyapatite gran-
ules showed good radiopacity. Histological analysis revealed less quantity of newly formed bone in
the ovariectomized group not submitted to hormone replacement therapy. In conclusion, bone neo-
formation can be expected even in bones compromised by estrogen deﬁciency, but the quantity and
velocity of bone formation are lower.Microsc. Res. Tech. 75:133–137, 2012. VC 2011 Wiley Periodicals, Inc.
INTRODUCTION
The World Health Organization deﬁnes osteoporosis
as a systemic skeletal disease that is characterized by
a reduction of bone mass and deterioration of bone
microarchitecture, with a consequent increased of bone
fragility and susceptibility to fracture (1993). The fre-
quency of osteoporosis and its associated fractures vary
according to gender and race/ethnic background. White
women with a low weight and body mass index, associ-
ated with estrogen deﬁciency especially during the
postmenopausal period, are more predisposed to the
loss of bone mass and, consequently, to the develop-
ment of osteoporosis (NIH Consensus Development
Panel on Osteoporosis Prevention, 2001).
Female gonadal hormones such as estrogen stimu-
late osteogenic activity and bone mineralization
(Lincoln and Tyler, 1999; Riggs et al., 2003), with the
observation of a direct association between bone mass
loss and estrogen deﬁciency. The extensive information
about this relationship emphasizes the importance of
estrogen in bone tissue homeostasis in both laboratory
animals and humans (Lormeau et al., 2004). The most
important effect of estrogen on bone remodeling is a
reduction of bone resorption. The drop in hormone lev-
els seen during the postmenopausal period, leads to a
predominance of cell resorption and consequent osteo-
porosis, predisposing the patient to pathological bone
fractures (Hawker, 1996; Ito et al., 2002). As a treat-
ment alternative, depending on the volume of bone
loss, implants of natural or synthetic biomaterials can
be used that act as a support for bone regeneration
(Hench, 1998).
The biomaterial implanted should meet some requi-
sites, such as a stable structure, being able to promote
osteoconduction, rapid incorporation into bone tissue,
and causing few or no complications (Rosen and
McFarland, 1990). One of the materials that fulﬁlls
these requirements is calcium phosphate, a ceramic
biomaterial that has been commercialized in the form
of hydroxyapatite and calcium triphosphate since 1970
(Costantino et al., 1992). Therefore, since hydroxyapa-
tite resembles the mineral apatite present in human
bone, this biomaterial has been widely used in dental
and orthopedic surgeries (LeGeros, 2002; Schmitz
et al., 1999). The advantages of this biomaterial
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include its biocompatibility, controllable porous micro-
structure, and its ability to facilitate the inﬁltration of
newly formed bone, characterizing its osteoconductiv-
ity (Ono et al., 2000). However, a good health status of
the recipient bone is necessary for a good interaction
between bone and biomaterials; otherwise, the results
are unsatisfactory (Cunha et al., 2008).
The objective of this study was to evaluate by histo-
logical and radiographic methods, the osteogenic
capacity of hydroxyapatite Ca10(PO4)6(OH)2 (Gen-
Phos HA TCP Genius-Baumer S.A.) implanted into the
femur of rats with osteoporosis due to estrogen deﬁ-
ciency induced by bilateral ovariectomy.
MATERIALS ANDMETHODS
Animals
Eighteen female rats (Rattus norvegicus) maintained
under standard conditions of housing and feeding at
the animal house of the Faculty of Medicine of Jundiaı´
(FMJ), Jundiaı´, Sa˜o Paulo, Brazil, were used. The ani-
mals were divided into three groups: not ovariectom-
ized (NO), bilaterally ovariectomized not receiving
hormone replacement therapy (BOWHR), and bilater-
ally ovariectomized and submitted to hormone replace-
ment therapy (BOHR).
The study was conducted in accordance with institu-
tional ethical guidelines and was approved by the
Ethics Committee of FMJ, Jundiaı´, Sa˜o Paulo, Brazil
(protocol 17/2009–2010).
Ovariectomy
All rats, except for NO animals, were weighed and
anesthetized by intramuscular injection of ketamine
(Francotar, Sespo Ind. e Com., Jacareı´, Sa˜o Paulo, Bra-
zil) and xylazine hydrochloride (2% Virbaxyl, Virbac
Brasil Ind. e Com., Sa˜o Paulo, Brazil) at a proportion of
1:1 and a dose of 0.10 mL/100 g body weight. A 2-cm
incision was made in the skin with a scalpel lateral to
the spine to completely remove the ovary from the pel-
vic cavity. The musculature and skin were repositioned
and closed with No. 4.0 cotton suture sterilized (Nylon,
Technoﬁo).
Surgical Procedure for the Implantation of
Hydroxyapatite
Particles of 0.5–0.75 mm of hydroxyapatite
Ca10(PO4)6(OH)2 (GenPhos HA TCP Genius-Baumer
S.A.) were implanted 4 months after surgery, according
to (Wronski et al., 1989). After anesthesia as described
above, an incision was made in the skin on the medial
side of the thigh, exposing the femoral quadriceps mus-
cle. The muscle was sectioned longitudinally in its dis-
tal third and separated anterolaterally. With the distal
end of the diaphysis of the left femur exposed and the
periosteum separated, a bone defect was created with a
3-mm hand-held surgical drill. Next, the defect was
ﬁlled with hydroxyapatite. The periosteum, muscula-
ture and skin were repositioned and closed with No.
4.0 cotton suture. The animals were sacriﬁced 8 weeks
after implantation and the femurs containing the
recipient area were removed and submitted to radiolog-
ical, histological, and morphometric analysis.
Hormone Replacement Therapy
Estradiol (b-estradiol, Sigma, St. Louis, MO) was
used for hormone replacement therapy. The drug was
diluted in peanut oil (All Chemistry, Sao Paulo, Brazil)
and the animals were injected s.c. with 20 mg at mean
intervals of 48 h from the time of hydroxyapatite
implantation to the day of sacriﬁce after 8 weeks.
Radiography and Histological Analysis
Radiographs of the left femurs were obtained with a
Rigaku RU-200 apparatus at a focal point of 0.8 3
0.8 mm. Kodak radiographic ﬁlms measuring 7.6 3
5.7 mm were used. After radiological analysis, the sam-
ples were submitted to routine histological processing
and semiserial 5-lm cross-sections were stained with
hematoxylin and eosin.
Morphometric and Statistical Analysis
The quantity of newly formed bone at the site of the
hydroxyapatite implant was calculated for each recipi-
ent area using a 100-point square grid coupled to the
eyepiece of a light microscope, following histomorpho-
metrical methods (Mandarim de Lacerda, 1999). The
results were analyzed by ANOVA (P < 0.05) followed
by the Tukey test, using the software BIOESTAT 5.0.
RESULTS
Macroscopic Analysis
In the studied groups, it was not observed in the
grafted area, pathological alterations such as inﬂam-
matory processes, pseudoarthrosis, bone erosions,
ulcerative lesions, cysts, or other rejection signs like as
infection, suggesting a biocompatibility of the hydroxy-
apatite used (Fig. 1).
Radiological Analysis
Good radiopacity of the implant recipient area and
hydroxyapatite granules was observed in the studied
groups (NO, BOWHR, and BOHR). In addition, the
presence of a cluster of granules indicated the absence
of their migration to distant sites. Discrete points of
radiolucency were noted between granules, indicating
connective tissue inﬁltration (Fig. 2).
Histological Analysis
Formation of new bone around the hydroxyapatite
granules was observed in the studied groups, in addi-
tion to the proliferation of connective tissue. However,
projections of more voluminous newly formed bone
were more evident in the NO and BOHR groups and
containing cavities ﬁlled with bone marrow (Figs. 3A
and 3C). In the BOWHR group, the quantity of newly
formed bone was lower (Fig. 3B).
In all groups, a bone layer around the implant show-
ing characteristics of trabecular and cortical bone were
observed. A tendency of new bone tissue migration par-
tially covering the bone defect was observed in NO and
BOHR (Figs. 3A–3C). The newly formed bone pre-
sented characteristics of immaturity; lacunae harbor-
ing osteocytes arranged in various directions as well as
mature (dense texture) bone (Figs. 3D–3F). No ﬁbrous
tissue capsule or inﬂammatory process in the implant
recipient area was observed in any of the groups.
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Hydroxyapatite presence presented similar aspects
of the amorphous materials, acellular, well deﬁned
shape and with higher afﬁnity to hematoxylin (Fig. 3).
Morphometric Analysis
Statistical analysis showed a similar quantity of
newly formed bone in the recipient area of NO (36.6 6
1.1402) and BOHR (32.4 6 0.8944) animals, which was
signiﬁcantly higher than that observed in the BOWHR
group (12.66 1.1402).
DISCUSSION
Despite the applicability of hydroxyapatite as a bone
implant, some factors, including diseases associated
with bone mineral deﬁciency such as osteoporosis, may
compromise the promising results reported in the liter-
ature. According to Frayssinet et al. (1992) the health
conditions of bone are fundamental for its interaction
with the implant biomaterial. Factors that increase the
risk for osteoporosis development include a low calcium
intake, smoking, alcoholism, lack of physical activity,
and hormonal disorders resulting from early meno-
pause or late menarche (Pinheiro et al., 2008; Shen
et al., 2000). The risk of osteoporosis is also increased
with ovariectomization (Lincoln and Tyler, 1999), con-
sidering that female gonadal hormones such as estro-
gen stimulate bone growth and mineralization
(Wronski et al., 1989). Therefore, this research was
able to evaluate the osteoconductive capacity of hy-
droxyapatite in bone tissue affected by the hormone
deﬁciency effects through ovariectomy procedures.
Ovariectomized animals as it was used in this
research are frequently employed for the study of post-
menopausal osteoporosis. However, some discrepancies
are reported in the literature regarding the interaction
between bone and implants of biomaterials such as ti-
tanium and ceramics. Some studies have shown signiﬁ-
cant bone loss around these biomaterials, whereas
others reported no difference in bone growth in the re-
cipient areas of ovariectomized animals (Fini et al.,
1997; Hayashi et al., 1994; Pan et al., 2000). This diver-
gence might be due to the difﬁculty in standardizing
methods for the correct quantiﬁcation of bone tissue
formed on the implant (Ozawa et al., 2002). In addition,
few studies have characterized hydroxyapatite bioma-
terials introduced into bone defects created in ovariec-
tomized rats in terms of the quantity and mechanical
strength of the bone formed in the recipient area.
Several studies have reported the deleterious effects
of ovariectomy on the characteristics and properties of
bone tissue, such as a reduced strength to withstand
external mechanical loads (Giavaresi et al., 2004).
According to Mizutani et al. (2000) hypoestrogenism
increases bone resorption and reduces trabecular bone
mass, thus affecting the biomechanical strength of
bone. However, the authors cited above did not study
any type of implant. However, Ozawa et al. (2002)
implanted titanium into bone defects created in the fe-
mur of ovariectomized rats. Biomechanical tests per-
formed after 2 weeks showed that the mechanical
strength in the recipient area of ovariectomized rats
was half that found in nonovariectomized animals.
To study the bone-implant interaction in cases of
osteoporosis induced by hormone alterations, some
investigators performed ovariectomy in rats and then
implanted titanium into the bone cavities produced in
these animals. The authors noted poor interaction
between the material implanted and bone tissue, as
well as a low amount of newly formed bone, and attrib-
uted the ﬁndings to the osteoporosis-like conditions as
a result of gonadal deﬁciency induced by ovariectomy
(Hayashi et al., 1994; Lugero et al., 2000). Similar
results have been reported by De Benedittis et al.,
(1999); Fini et al., (1997); Hayashi et al., (1994); Jung
et al., (2001); and Pan et al., (2000), who used hydroxy-
apatite as implant material. Cunha et al., (2008) con-
ﬁrmed the effects of estrogen deﬁciency on the delay of
bone regeneration in defects created experimentally in
the femur of ovariectomized rats and ﬁlled with colla-
gen membranes. According to Albrektsson et al. (1981),
bone health status is essential for the interaction of
bone with biomaterial implants.
In this study, a lower quantity of newly formed bone
was observed in ovariectomized animals not submitted
to hormone replacement therapy (BOWHR) and simi-
lar quantity of newly formed bone was observed in
nonovariectomized (NO) animals and ovariectomized
animals submitted to hormone replacement therapy
(BOHR), with the quantity of newly formed bone being
higher than that observed in the BOWHR group. These
ﬁndings suggest the inﬂuence of estrogen on both the
process of osteogenesis and the type of new bone. Simi-
lar results have been reported by (Cho et al., 2004),
who studied the bone-dental implant interface in ovar-
iectomized rats and observed a reduction of the cortical
layer and an increase of trabecular bone in the recipi-
ent area. The authors concluded that osteoporosis
Fig. 1. Anterior view of the implant recipient area in the left fe-
mur of nonovariectomized rats (A: NO), animals submitted to bilat-
eral ovariectomy without hormone replacement therapy (B:
BOWHR), and bilaterally ovariectomized animals submitted to estro-
gen replacement therapy (C: BOHR). Note the recipient area (arrow)
grafted with hydroxyapatite granules without evidence of infectious
foci.
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induced by estrogen deﬁciency might compromise the
mechanical stability of the implant area.
Aiming to evaluate the bone-implant interaction
considering the osteoporosis condition induced by hor-
monal alterations, some researches performed ovariec-
tomy in rats and after this surgical procedure,
implanted titanium into the bone gaps created in these
animals. The histological ﬁndings presented a poor
interaction between the inserted material and bone tis-
sue, and a low amount of newly formed bone, and were
attributed to the osteoporosis-like conditions as a
result of gonadal deﬁciency induced by ovariectomiza-
tion procedure (Li et al., 2004; Lugero et al., 2000; Pan
et al., 2000; Wang et al., 2005). Similar ﬁndings have
also been reported by De Benedittis et al. (1999), Fini
et al. (1997), Hayashi et al. (1994); Jung et al. (2001),
who, however, used hydroxyapatite as implant mate-
rial. Statistical analysis did not revealed statistical dif-
ference between the BOHR and NO, but these two
groups were different in relation to the BOWHR group.
This analysis conﬁrms the effects of estrogen deﬁciency
on bone metabolism in response to the implant used.
Thus, bone neoformation can be expected even in ovar-
iectomized animals, but it is slower and the bone
volume is smaller. In addition, we noted the presence
of trabecular bone in the implanted areas of group
BOHR. Similar results have been reported by (Cho
et al., 2004; Cunha et al., 2010), who studied the bone-
implant interface in ovariectomized rats. The authors
concluded that osteoporosis-like conditions induced by
hormone deﬁciency might compromise the mechanical
stability of the implant in view of the results demon-
strating a reduction of the cortical layer and an
increase of trabecular bone in the recipient area.
Biomaterials as hydroxyapatite may be performed for
clinical application aiming to improve the bone healing
process. The porous of these substances are well toler-
ated by bone tissue in addition to facilitate osteoblasts
inﬁltration and proliferation of blood vessels, essential
phenomena of regenerative process (Shirane et al.;
Thomson et al., 1998). Hydroxyapatite granules become
possible the migration and union of the osteoblastic
cells, resulting in new bone formation (LeGeros, 2002).
In this research, hydroxyapatite granules with particles
of 0.5–0.75 mm of diameter were used.
According to the macroscopic results of this research,
it was not found signs of rejection of hydroxyapatite,
conﬁrming the biocompatibility of this substance
(Oonishi et al., 1997; Schmitz et al., 1999; Shirane
et al.; Yamamoto et al., 2000).
Radiological observations showed that the radiopacity
of hydroxyapatite was more intense than that the nor-
mal bone, which was also described by Rezende et al.
(1998) and Vital et al. (2006). This can be explained by
chemical formula of the hydroxyapatite, which depends
on its chemical constituents (Ono et al., 2000). Between
the hydroxyapatite granules, it was observed radiolu-
cency due to the presence of the connective tissue; how-
ever, did not differ visually between groups.
It was concluded that the hydroxyapatite used in this
study showed to be biocompatible, because there any
clue for rejection of the implant. Considering the
Fig. 2. Radiographs of the implant recipient area in the left femur
of nonovariectomized rats (A: NO), animals submitted to bilateral
ovariectomy without hormone replacement therapy (B: BOWHR),
and bilaterally ovariectomized animals submitted to estrogen replace-
ment therapy (C: BOHR). Note that the arrow represents the radio-
pacity of hydroxyapatite granules implanted into the distal epiphysis
of the femur.
Fig. 3. Histological images of the implant recipient area in the left
femur of nonovariectomized rats (A and D: NO), animals submitted to
bilateral ovariectomy without hormone replacement therapy (B and
E: BOWHR) and bilaterally ovariectomized animals submitted to
estrogen replacement therapy (C and F: BOHR). Note the formation
of new bone (*) around the hydroxyapatite granules (ha), especially in
the NO and BOHR groups. Note thin layer the newly formed bone in-
group BOWHR. OC, cortical bone; OT, trabecular bone; TC, connec-
tive tissue; BM, bone marrow. Arrow shows osteocyte in lacunae.
Figures 3A–3C (34) and Figures 3D and 3E (310). [Color ﬁgure can
be viewed in the online issue, which is available at wileyonlinelibrary.
com.]
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animals of the NO and BOHR groups, the bone healing
process occurred faster conﬁrming the osteoconductive
properties of the hydroxyapatite in health bone tissue.
In addition, this study showed that bone neoformation
even occurs in bone compromised by osteoporosis due to
gonadal deﬁciency, especially when the defect is ﬁlled
with hydroxyapatite like those used in this study but
the quantity and velocity of bone formation are lower.
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